68 related articles for article (PubMed ID: 18439753)
1. Cell cycle regulated phosphorylation of LIMD1 in cell lines and expression in human breast cancers.
Huggins CJ; Andrulis IL
Cancer Lett; 2008 Aug; 267(1):55-66. PubMed ID: 18439753
[TBL] [Abstract][Full Text] [Related]
2. Identification of rare variants in the hLIMD1 gene in breast cancer.
Huggins CJ; Gill M; Andrulis IL
Cancer Genet Cytogenet; 2007 Oct; 178(1):36-41. PubMed ID: 17889706
[TBL] [Abstract][Full Text] [Related]
3. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
4. The tumor suppressor Scrib interacts with the zyxin-related protein LPP, which shuttles between cell adhesion sites and the nucleus.
Petit MM; Meulemans SM; Alen P; Ayoubi TA; Jansen E; Van de Ven WJ
BMC Cell Biol; 2005 Jan; 6(1):1. PubMed ID: 15649318
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
6. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
7. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
[TBL] [Abstract][Full Text] [Related]
8. LIMD1 antagonizes E2F1 activity and cell cycle progression by enhancing Rb function in cancer cells.
Mayank AK; Sharma S; Deshwal RK; Lal SK
Cell Biol Int; 2014 Jul; 38(7):809-17. PubMed ID: 24523249
[TBL] [Abstract][Full Text] [Related]
9. Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells.
Mizuma M; Katayose Y; Yamamoto K; Shiraso S; Sasaki T; Yabuuchi S; Oda A; Masuda K; Rikiyama T; Onogawa T; Ohtsuka H; Motoi F; Egawa S; Unno M
Anticancer Res; 2008; 28(5A):2669-77. PubMed ID: 19035293
[TBL] [Abstract][Full Text] [Related]
10. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.
Helms MW; Kemming D; Contag CH; Pospisil H; Bartkowiak K; Wang A; Chang SY; Buerger H; Brandt BH
Cancer Res; 2009 Jun; 69(12):5049-56. PubMed ID: 19491269
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
12. LIMD1 phosphorylation in mitosis is required for mitotic progression and its tumor-suppressing activity.
Zhou J; Zhang L; Zhou W; Chen Y; Cheng Y; Dong J
FEBS J; 2019 Mar; 286(5):963-974. PubMed ID: 30600590
[TBL] [Abstract][Full Text] [Related]
13. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
14. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
[TBL] [Abstract][Full Text] [Related]
15. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression.
Perera CN; Chin HG; Duru N; Camarillo IG
J Endocrinol; 2008 Nov; 199(2):221-33. PubMed ID: 18715880
[TBL] [Abstract][Full Text] [Related]
16. The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development.
Sharp TV; Al-Attar A; Foxler DE; Ding L; de A Vallim TQ; Zhang Y; Nijmeh HS; Webb TM; Nicholson AG; Zhang Q; Kraja A; Spendlove I; Osborne J; Mardis E; Longmore GD
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19932-7. PubMed ID: 19060205
[TBL] [Abstract][Full Text] [Related]
17. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
Moh MC; Zhang T; Lee LH; Shen S
Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
[TBL] [Abstract][Full Text] [Related]
18. Regucalcin is under-expressed in human breast and prostate cancers: Effect of sex steroid hormones.
Maia C; Santos C; Schmitt F; Socorro S
J Cell Biochem; 2009 Jul; 107(4):667-76. PubMed ID: 19347872
[TBL] [Abstract][Full Text] [Related]
19. Differential subcellular localisation of the tumour suppressor protein LIMD1 in breast cancer correlates with patient survival.
Spendlove I; Al-Attar A; Watherstone O; Webb TM; Ellis IO; Longmore GD; Sharp TV
Int J Cancer; 2008 Nov; 123(10):2247-53. PubMed ID: 18712738
[TBL] [Abstract][Full Text] [Related]
20. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.
Montano X
Oncogene; 2009 Oct; 28(43):3787-800. PubMed ID: 19749791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
